This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hagege, J. Articles by Sraer, J. D. Search for Related Content PubMed PubMed Citation Articles by Hagege, J. Articles by Sraer, J. D.

American Journal of Pathology, Vol 141, 117-128, Copyright © 1992 by American Society for Investigative Pathology

REGULAR ARTICLES

Plasminogen activator inhibitor-1 deposition in the extracellular matrix of cultured human mesangial cells

J Hagege, MN Peraldi, E Rondeau, C Adida, F Delarue, R Medcalf, WD Schleuning and JD Sraer
INSERM U64, Hopital Tenon, Paris, France.

Human mesangial cells secrete tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1), the latter being secreted in large excess in vitro. We demonstrate that PAI-1 is a major component of the extracellular matrix of cultured human mesangial cells, where its deposition is dependent on cell density. By immunogold silver staining, epipolarization microscopy and dispersive X-ray spectrometry, we have shown that matrix-associated PAI-1 is synthesized by spreading human mesangial cells, as indicated by the time-dependent accumulation of PAI-1 and the inhibitory effect of cycloheximide. Furthermore, by in situ hybridization, PAI-1 mRNA was detected in cultured mesangial cells. t-PA is present inside the cells, or at the cell surface, but is never associated with the extracellular matrix. Exogenous t-PA can remove matrix-associated PAI-1 without affecting cell adhesion. A similar effect was obtained by addition of urokinase- type plasminogen activator (u-PA) but not with fibrinolysis unrelated enzymes. In conclusion, PAI-1 is synthesized by human cultured mesangial cells and is deposited in the extracellular matrix by nonconfluent cells, whereas less PAI-1 is seen between confluent cells. This can explain the absence of detectable PAI-1 in normal human kidney biopsies. t-PA released by mesangial cells can bind and detach matrix PAI-1.

This article has been cited by other articles:

				C. Yang and W. F. Glass II Expression of {alpha}-Actinin-1 in Human Glomerular Mesangial Cells In Vivo and In Vitro Experimental Biology and Medicine, June 1, 2008; 233(6): 689 - 693. [Abstract] [Full Text] [PDF]

				A. Hertig and E. Rondeau Role of the Coagulation/Fibrinolysis System in Fibrin-Associated Glomerular Injury J. Am. Soc. Nephrol., April 1, 2004; 15(4): 844 - 853. [Abstract] [Full Text] [PDF]

				C. Y. Song, B. C. Kim, H. K. Hong, B. K. Kim, Y. S. Kim, and H. S. Lee Biphasic regulation of plasminogen activator/inhibitor by LDL in mesangial cells Am J Physiol Renal Physiol, September 1, 2002; 283(3): F423 - F430. [Abstract] [Full Text] [PDF]

				T. M. Coffman, R. F. Spurney, R. B. Mannon, and R. Levenson Thromboxane A2 modulates the fibrinolytic system in glomerular mesangial cells Am J Physiol Renal Physiol, August 1, 1998; 275(2): F262 - F269. [Abstract] [Full Text] [PDF]

				M. P. Emert, C. M. Sorenson, D. P. Basile, J. G. Rogers, M. R. Hammerman, and J. J. Billadello The human plasminogen activator inhibitor type I gene promoter targets to kidney Am J Physiol Renal Physiol, February 1, 1998; 274(2): F405 - F412. [Abstract] [Full Text] [PDF]

				W. P. Fay, A. C. Parker, L. R. Condrey, and A. D. Shapiro Human Plasminogen Activator Inhibitor-1 (PAI-1) Deficiency: Characterization of a Large Kindred With a Null Mutation in the PAI-1 Gene Blood, July 1, 1997; 90(1): 204 - 208. [Abstract] [Full Text] [PDF]